Skip to main content
. 2016 Mar 9;7(16):22064–22076. doi: 10.18632/oncotarget.8017

Figure 2. Occurrence of clinical trial recommendations.

Figure 2

Mutated genes from highest to lowest number of sources are listed along x-axis and number of clinical trials grouped by number of contributing sources are stacked along y-axis.